Built for doctors preparing for NPMCN, WACP & WACS.
ReviseMed is the focused, mobile-first revision platform for postgraduate medical examinations in West Africa — past exam recalls and mocks, past picture stations, and the clinical exam resources you need to walk into your exam ready.
Our mission
To make high-quality, exam-focused revision accessible and affordable for every doctor sitting the NPMCN, WACP and WACS examinations — regardless of where they trained or where they practise.
Our story
ReviseMed started from a simple frustration: there was no structured, recall-based question bank tailored to the realities of Part 1 postgraduate medical exams. Candidates were stitching together photocopies, group chats and foreign banks that never quite matched the syllabus or question style.
We built ReviseMed to fix that — a single, well-organised platform where you can practise the right questions, work through past picture stations, prepare for the clinicals, see how you're really performing, and revise on the device you already carry on the wards.
What we offer
Everything you need between today and exam day
Question Bank
Every question is built from a real past paper recall and tagged by college, faculty and subject. Practise in focused sets, sit timed mocks, and let your weak-areas list tell you what to revise next.
See coverageWhy ReviseMed
The principles behind every question
Exam-relevant
Every question and station maps to the postgraduate curriculum.
Mobile-first
Designed to revise on call, on transit, on the go.
Affordable in Naira
Priced for doctors in Nigeria and across West Africa.
Continuously updated
New recalls, stations and explanations added every cycle.
The company behind ReviseMed
ReviseMed is operated by Sigma Analytics and Tech Solutions LTD, a Nigerian health-technology company focused on improving medical education and healthcare delivery through thoughtful digital products.
Ready to revise smarter?
Join doctors across Nigeria and West Africa preparing for their next postgraduate exam with ReviseMed.